Durkin, Alan J <br/><br/>
EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma.  [electronic resource] 

 -  The Journal of surgical research  Sep 2006 
 - 195-201 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-4804 
<br/><br/><label>Standard No.: </label>10.1016/j.jss.2006.03.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Cell Division--drug effects<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Gene Expression<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Pancreatic Neoplasms--drug therapy<br/>Phenylalanine--analogs & derivatives<br/>Protease Inhibitors--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinazolines--pharmacology<br/>Survival Rate<br/>Thiophenes--pharmacology